C12N 2710/16152
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2710/16152 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 28 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Methods for producing cmv vectors1 May 2025US 2025/0136949 A1Vir Biotechnology, Inc.
- Modified cytomegalovirus proteins and stabilized complexes9 Jan 2025US 2025/0009874 A1Glaxosmithkline Biologicals SA
- Modified cytomegalovirus proteins and stabilized complexes10 Aug 2023US 2023/0248820 A1Glaxosmithkline Biologicals SA
- Hcmv vaccine strain29 Jul 2021US 2021/0230228 A1
- Vaccine against beta-herpesvirus infection and use thereof25 Apr 2019US 2019/0117766 A1
Most cited
By later US patents